Vericel Corporation (VCEL)
NASDAQ·Healthcare·Biotechnology
$41.37
-4.30%
Mkt Cap $2.18B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (16 analysts)
$61.33
Range $54.00 – $70.00
Implied Upside
+48.2%
Consensus $61.33 vs current $41.37
NASDAQ·Healthcare·Biotechnology
$41.37
-4.30%
Mkt Cap $2.18B
Buy
7
Hold
0
Sell
0
Price Target (16 analysts)
$61.33
Range $54.00 – $70.00
+48.2%
Consensus $61.33 vs current $41.37